Andy is the COO / CBO at Grey Wolf Therapeutics, and brings a strong track record of building teams that deliver results. He has built businesses across multiple geographies and portfolios from start-up biotech to big pharma commercialisation, with notable leadership as the former CEO and President of Otsuka Pharmaceutical Company Europe. Andy is passionate about creating a culture that helps people achieve their full potential, and is a values-driven, pragmatic business leader who believes in innovative science to find new solutions for people living with the worlds most challenging illnesses.